Advertisement

Topics

Companies Related to "A Study of the Effects of Desloratadine on Conjunctival Allergen Challenge-Induced Ocular Signs and Symptoms (Study P04209)(COMPLETED)" [Most Relevant Company Matches] RSS

14:05 EST 18th February 2019 | BioPortfolio

Here are the most relevant search results for "A Study of the Effects of Desloratadine on Conjunctival Allergen Challenge-Induced Ocular Signs and Symptoms (Study P04209)(COMPLETED)" found in our extensive corporate database of over 50,000 company records.

Showing "Study Effects Desloratadine Conjunctival Allergen Challenge Induced Ocular" Companies 1–25 of 1,200+

Relevant

ProCertus BioPharm, Inc.

ProCertus BioPharm is an oncology-based pharmaceutical company whose primary mission is to protect cancer patients against the side effects of chemotherapy and radiotherapy.ProCertus has established proof of concept in animal models for its product candidates, DermX, ProDermaCel™, and OralX, proprietary pharmaceuticals designed to reduce or eliminate the side effects associated with cancer thera...


The MAX Challenge

The MAX Challenge is a ten-week body renewal system designed to help members make fast and lasting changes to their health, appearance and fitness levels. MAX Challenge members achieve great results by receiving a combination of nutritional counseling, fitness classes and motivation provided by trained MAX Challenge instructors. There are almost 50 MAX Cha...

Ocular Therapeutix, Inc. 

Ocular Therapeutix, Inc. (NASDAQ: OCUL) is a biopharmaceutical company focused on the development and commercialization of innovative therapies for diseases and conditions of the eye using its proprietary hydrogel platform technology. Ocular Therapeutix's lead product candidates are in Phase 3 clinical development for post-surgical ocular inflammation an...


Ora, Inc.

Ocular Therapeutix, Inc. is a biopharmaceutical company focused on the development and commercialization of innovative therapies for diseases and conditions of the eye using its proprietary hydrogel platform technology. Ocular Therapeutix’s lead product candidates are in Phase 3 clinical development for post-surgical ocular inflammation and pain and a...

Ocular Therapeutix, Inc.

Ocular Therapeutix, Inc. is a privately held company based in Bedford, MA, focused on the development and commercialization of ophthalmic therapeutic products using its proprietary hydrogel technology. Ocular Therapeutix is focusing on development of drug-eluting punctum plugs for treatment of glaucoma and post-operative inflammation and pain, injectable d...

Ocular Therapeutix™, Inc.

Ocular Therapeutix, Inc. is a biopharmaceutical company focused on the development, manufacturing and commercialization of innovative therapies for diseases and conditions of the eye using its proprietary hydrogel-based formulation technology. Ocular Therapeutix’s lead product candidate, DEXTENZA™ (dexamethasone insert) 0.4 mg for intracanalicular ...

Kala Pharmaceuticals Inc.

Kala Pharmaceuticals, Inc. is advancing innovative treatments for ocular diseases addressing significant needs in both front and back of the eye based on the company’s proprietary Mucus Penetrating Particle (MPP) platform technology. Kala’s topical ocular MPP formulations enhance penetration into ocular tissue by facilitating penetration through the ...

Sirion Therapeutics, Inc.

Herpetic Keratitis is the number one infectious cause of corneal blindness in the U.S. Herpes simplex virus infections are very common, with nearly 60% of the US population showing evidence of infection by age five. Approximately 1% of infected patients develop ocular outbreaks, with 20,000 primary cases of ocular herpes diagnosed in the US each year. After the primary infection, ocular HSV typic...

UC San Diego Entrepreneur Challenge

The UC San Diego Entrepreneur Challenge is a wholly student founded and operated non-profit organization with the mission of educating, connecting and funding aspiring student entrepreneurs at UCSD and surrounding research institutes. For more information: http://challenge.ucsd.edu

ChanTest Inc.

To provideNon-Clinical drug safety testing and discovery services that accelerate drug development by:Leveraging our extensive experience in evaluating drug-induced effects on ion channels, purkinje fibers, and iolated hearts; Providing accurate, repeatable results; Consistently responding with a high sense of urgency

Allergen Research Corporation

Allergen Research Corporation (ARC), founded in 2011, is developing treatments to protect children with food allergies from the life-threatening consequences of accidental exposure. ARC’s work, which builds on more than a decade of groundbreaking research in oral immunotherapy by the company’s academic and nonprofit collaborators, aims to establi...

brial allergen GmbH

Since the end of the 80ies, the official name of the company based in the Westphalian town of Greven has been brial allergen GmbH.Thanks to the combination of practice-oriented product development and extensive galenic experience, brial can offer a great variety of different epicutaneous contact allergens to its customers.In conjunction with numerous pharmaceutical services, brial offers its epicu...

Neurobehavioral Research Inc

NRI specializes in using EEG, structural MRI and neuropsychological and behavioral assessment to study the effects of drugs and diseases on brain structure and function. NRI also works towards developing new technologies to support this endeavor.

Chloraseptic(R) Allergen Block

Vaxin Inc.

Vaxin Inc. is a clinical stage biotechnology company, founded in December 1997 with facilities in Rockville, MD and Birmingham, AL, developing next generation vaccines to address significant public health and biodefense needs. Vaxin is focused on vaccines designed to protect people against influenza and anthrax infection using proprietary, patented technol...

Engineering Staff Solutions Limited

Over the next five years the sectors we provide service to face momentous challenge. There will be new technical challenges. The challenge of finding solutions to the problems faced in most areas of our infrastructure, both in the UK and many other parts of the globe. Then there will be the people challenge - having the right people, with the right skills, available at the right time and in the ri...

Ocular Surface Center, P.A.

Ocular Surface Foundation (OSF) is a non-profit public medical research foundation (501c3) established in 1999, and carries s single mission of promoting the spread of the knowledge and skills that are important for treating ocular surface diseases. Under the leadership of the President, Billy K. Yeh, M.D., Ph.D., OSF supports research and educational programs that may create a differentiable valu...

NPS Pharmaceuticals, Inc.

NPS Pharmaceuticals is developing new treatment options for patients with rare gastrointestinal and endocrine disorders. The company is currently advancing two Phase 3 registration programs. Teduglutide, a proprietary analog of GLP-2, is being evaluated as GATTEX® in a Phase 3 registration study known as STEPS for intestinal failure associated with shor...

Brain Injury Research Institute

The Brain Injury Research Institute is a center for the study of traumatic brain injuries and prevention, which is affiliated with the Blanchette Rockefeller Neuroscience Institute at West Virginia University. The purpose of the Institute is to study the short and long-term impact of brain injuries in order to better understand the impact of concussions, the development of chronic traumatic enceph...

Research Diets, Inc

Research Diets, Inc began producing and formulating custom purified-ingredient diets for lab animals. We have worked hand-in-hand with universities, CRO's, pharmaceutical companies, laboratories, non- profit and government institutions to provide diet solutions for specific diet induced disease models. One such model in the study of obesity led to the development of the "Original" High-Fat Diet se...

Guildford Clinical Pharmacology

Guildford Clinical Pharmacology Ltd (GCPL) has wide experience of efficient study designs in Phases 1 & 2 and develops new surrogate markers especialy for analgesics, the CNS and gastrointestinal drugs. We can use high tech equipment and the staff to run it correctly; recent examples being: 1) Gamma cameras for colonic transit measurements in a proof of efficacy study on a morphine antagonist an...

AsclepiX Therapeutics, Inc.

AsclepiX Therapeutics is transforming the treatment of ocular diseases and cancer with a singular focus on a novel peptide platform with the power to inhibit and potentially even reverse disease progression. The mechanism of action of AXT107 targets multiple pathways, including vascular endothelial growth factor A (VEGF-A) and Tie2, two factors that promot...

Team Escalade Texas

Team Escalade Texas was a charity challenge sponsored by Texas Cadillac Dealers that aims to increase public awareness and support for vital Texas charities. Six teams, 19 celebrities, four cities and one bold drive to save lives. The challenge ran through October 30, 2011.

SOOFT italia S.p.A.

SOOFT italia S.p.A. a Company of OOgroup , is an Italian pharmaceutical firm specialized in the research of new solutions , in carrying out and marketing of products for general and specific eyes health.SOOFT italia S.p.A. is mainly involved in the most common ocular pathologies, ranging from anterior segment (dry eye, ocular inflammations, periocular hygi...

International Society for the Study of Xenobiotics

Man's use of xenobiotics dates from antiquity but interest in foreign compound metabolism dates from only the mid-19th century when the knowledge and techniques of organic chemistry were first applied to its study. For nearly a century thereafter biotransformation was generally equated with "detoxication" or the elimination of a compound's biological activity.This view changed in the late 1930s wi...


More From BioPortfolio on "A Study of the Effects of Desloratadine on Conjunctival Allergen Challenge-Induced Ocular Signs and Symptoms (Study P04209)(COMPLETED)"

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks